首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 1期肝纤维化及肝硬化 => 综述 =>肝细胞癌肿瘤标志物的研究进展
肝细胞癌肿瘤标志物的研究进展
Research advances in tumor markers for the diagnosis of hepatocellular carcinoma
文章发布日期:2017年12月09日  来源:  作者:杨贵敏,赵运胜,王春华,等  点击次数:407次  下载次数:115次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:AFP是目前最常用的肝细胞癌(HCC)诊断标志物,但其敏感度和特异度均不够理想,尤其在HCC的早期阶段肿块较小时容易漏检。就目前出现的一些新的肿瘤标志物在HCC诊断、治疗监测和预后判断方面的临床价值进行归纳总结,并分析了HCC肿瘤标志物今后的发展趋势。认为多种肿瘤标志物联合检测有利于提高HCC诊断的敏感度和特异度,筛选和优化肿瘤检测组合、寻找无创且高效的肿瘤标志物及个性化治疗将是今后的研究热点。
【Abstract】:Hepatocellular carcinoma (HCC) is a malignant tumor with a high fatality rate in the world, and alpha-fetoprotein (AFP) is the most commonly used tumor marker for HCC diagnosis. However, AFP does not have a satisfactory sensitivity or specificity and may lead to missed diagnosis when the tumor is small in the early stage of HCC. This article summarizes the clinical value of new tumor markers in the diagnosis, treatment monitoring, and prognosis judgment of HCC and analyzes the future prospects of the measurement of tumor markers for HCC. It is pointed out that combined determination of several tumor markers helps to improve the sensitivity and specificity of HCC diagnosis, and the screening and optimization of combined determination of tumor markers, noninvasive and efficient tumor markers, and individualized treatment are research hotspots in future.
【关键字】:癌,肝细胞;肿瘤标记,生物学;诊断;综述
【Key words】:carcinoma, hepatocellular; tumor markers, biological; diagnosis; review
【引证本文】:YANG GM, ZHAO YS, WANG CH, et al. Research advances in tumor markers for the diagnosis of hepatocellular carcinoma[J]. J Clin Hepatol, 2018, 34(1): 199-203. (in Chinese)
杨贵敏, 赵运胜, 王春华, 等. 肝细胞癌肿瘤标志物的研究进展[J]. 临床肝胆病杂志, 2018, 34(1): 199-203.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号